| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd21481bba459d56ae506885d899648c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ca91942e3acf8fe6e0037ea6521cc7 |
| publicationDate |
2022-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022235654-A1 |
| titleOfInvention |
Etelcalcetide formulations |
| abstract |
Disclosed herein are pharmaceutical formulations comprising etelcalcetide or salt thereof and a surfactant in aqueous solution, wherein the formulation has a pH of 2.0 to 5.0. |
| priorityDate |
2021-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |